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arousal, reward, motivation, and sensorimotor integra-
tion (Bittencourt et al., 1992; Marsh et al., 2002; Saw-
chenko, 1998).
MCH neurons may play a role in energy homeostasis.
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(Qu et al., 1996), and blockade of the MCH receptorNew Haven, Connecticut 06520
with antagonists reduces body weight (Borowsky et al.,2 Columbus Children’s Research Institute
2002). Food deprivation and leptin alter expression ofOhio State University
MCH and c-fos mRNA in MCH neurons (Qu et al., 1996;Columbus, Ohio 43205
Huang et al., 1999). MCH peptide (Shimada et al., 1998)
and receptor (Marsh et al., 2002) knockout mice eat
less, have reduced body weights, and show increasedSummary
activity. It has been suggested that another orexigenic
peptide, neuropeptide Y (NPY), which also stimulatesNeurons that synthesize melanin-concentrating hor-
food intake, acts by stimulating the MCH neuronsmone (MCH) may modulate arousal and energy ho-
(Schwartz et al., 2000). MCH neurons may also play ameostasis. The scattered MCH neurons have been
role in memory and depression (Borowsky et al., 2002).difficult to study, as they have no defining morphologi-
As MCH neurons are scattered within the hypothala-cal characteristics. We have developed a viral ap-
mus and have no distinct morphological attributes, itproach with AAV for selective long-term reporter gene
has been difficult to identify the live neurons in order(GFP) expression in MCH neurons, allowing the study
to record from them. We have solved this problem byof their cellular physiology in hypothalamic slices.
designing a recombinant adeno-associated virus (AAV)MCH neurons showed distinct membrane properties
that expresses a reporter gene, GFP, only in MCH neu-compared to other neurons infected with the same
rons and appears to have no adverse effect on neuronvirus with a cytomegalovirus promoter. Transmitters
health. Although many cells may be infected by the virus,of extrahypothalamic arousal systems, including nor-
only those cells that contain immunoreactivity for theepinephrine, serotonin, and the acetylcholine agonist
MCH peptide show reporter gene expression. The virusmuscarine, evoked direct inhibitory actions. Orexi-
should work to identify MCH neurons in a wide varietygenic neuropeptide Y was inhibitory by pre- and post-
of species, as suggested by experiments here in bothsynaptic mechanisms; an anorexigenic melanocortin
rats and mice. This approach has allowed us to studyagonist had no effect. In contrast, the hypothalamic
the membrane properties, synaptic activity, and mecha-arousal peptide hypocretin/orexin evoked a direct in-
nisms of transmitter responses in hypothalamic slicesward current and increased excitatory synaptic activ-
from rodents injected in vivo with the recombinant virus,ity and spike frequency in the normally silent MCH
and we have corroborated these findings with parallelneurons. Together, these data support the view that
slice experiments from MCH-GFP transgenic mice. WeMCH neurons may integrate information within the
tested the responses of MCH neurons to two groups ofarousal system in favor of energy conservation.
neuromodulators that are found in axons in the LH: those
that play a role in arousal, such as norepinephrine (NE),Introduction
serotonin (5HT), and acetylcholine (ACh), which were all
inhibitory; and those that function in energy homeosta-
Neurons that synthesize and release the neuropeptide sis, including opiomelanocortin peptides, which had no
melanin-concentrating hormone (MCH) are found con- detectable effect, and neuropeptide Y, which was inhibi-
centrated within the dorsal lateral hypothalamus (LH) tory. Hypocretin/orexin neurons that are implicated in
and also scattered in the medial hypothalamus and peri- arousal and energy homeostasis (de Lecea et al., 1998;
fornical area (Bittencourt et al., 1992). Axons from these Sakurai et al., 1998) make contact with MCH neurons,
neurons project widely throughout the CNS and, in par- and hypocretin has a profound excitatory effect on MCH
allel, the rodent MCH receptor SLC1 has a wide distribu- neurons. These results suggest that MCH neurons may
tion from the spinal cord to the cerebral cortex (Cham- integrate within the arousal system of the brain.
bers et al., 1999; Saito et al., 1999). The neurons of the
LH respond to a remarkably wide variety of sensory Results
stimuli, including olfactory, auditory, gustatory, and vi-
sual signals, and receive information from the gut (Rolls, Selectivity of Viral Expression in MCH Neurons
1984). Lesions of the LH result in sensory neglect. Given In the present study, we generated a replication-incom-
the widespread receptor expression and axon projec- petent AAV with GFP expression controlled by the MCH
tions, many of which terminate in other regions of the peptide promoter (Figure 1). A tripartite plasmid was
brain that play a role in arousal, including the locus transfected into HeLa cells, and cells expressing high
coeruleus, dorsal raphe, and dorsal tegmentum, MCH levels of virus were cloned and used for virus production.
neurons have been postulated to play a role in cognitive The recombinant AAV was highly purified by HPLC and
column chromatography and then injected into the
brains of lab rats and mice.*Correspondence: anthony.vandenpol@yale.edu
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A number of experiments were undertaken to assess and 3B). In contrast to AAV-MCH, another virus that we
the selectivity of reporter gene expression. After virus constructed with GFP driven by a nontranslated 0.7 kb
inoculation of the rat brain (n  9), serial sections were sequence upstream from the coding region of the neuro-
analyzed through the brain near the injection site needle peptide Y gene did express GFP in the cortex, hippo-
track. Only regions of the brain where MCH neurons campus, and thalamus.
had been previously reported (Bittencourt et al., 1992) We also generated transgenic mice in which GFP was
showed GFP expression with rAAV-MCH. GFP expres- regulated by the mouse MCH promoter. GFP-positive
sion was found in the cell body, proximal dendrites, and neurons in the transgenic mouse were all immunoreac-
axons of positive neurons (Figures 1B and 1C). GFP tive with MCH antisera (100 cells examined), and the
was found only in cells with a neuronal morphology; no anatomical distribution of positive neurons in the trans-
expression was found in glial cells. Neurons that showed genic mouse was similar to the distribution found with
GFP expression consistently also showed Texas red AAV-MCH and with MCH immunocytochemistry. The
immunostaining (Figures 2A–2D). In each of four brains, selective expression of GFP in the transgenic mouse
75 GFP-positive cells (300 total) were examined for MCH provides further support for the view that AAV-MCH was
immunoreactivity. Of 300 cells, 294 showed MCH immu- selective for MCH cells and provides another tool to
noreactivity. Six cells that showed little immunoreactiv- corroborate the MCH electrophysiological findings de-
ity were found in the LH; the absence of immunostaining scribed below.
could be due to poor penetration of the immunoreagents. A recombinant AAV with GFP driven by the CMV ie1
Although almost all GFP-expressing cells also showed promoter was compared with rAAV-MCH for control pur-
MCH immunoreactivity, a number of MCH-immunoreac- poses in the mouse brain (n  10). Unlike with rAAV-
tive neurons showed no GFP expression, particularly MCH, where expression was restricted to the hypothala-
when only one side of the brain was injected with rAAV- mus, GFP expression with rAAV-CMV was detected in
MCH. This is consistent with the view that the virus many areas of the brain after intracerebral inoculation,
would not necessarily infect all MCH cells, only those including cortex, hippocampus, thalamus, and hypo-
to which it diffused. thalamus. At the injection site, most cells appeared to
MCH and hypocretin are not colocalized (Peyron et al.,
be labeled at the center of the injection, with decreasing
1998). Although GFP and hypocretin immunoreactivity
numbers found as the distance from the injection site
were found in the same histological section, no expres-
increased. Cells with the morphology of both neurons
sion of GFP was found in hypocretin-immunoreactive
(cell body with from two to four primary dendrites andneurons (Figures 2E and 2F).
a single axon) and glia (cells with 10 to 30 processesIn sections where GFP-expressing cells were found
typical of astrocytes and no axon) were found afterin the hypothalamus after rAAV-MCH application, no
in vivo inoculation with AAV-CMV (Figures 3C–3G). Ex-GFP-expressing cells were found in the cortex, hippo-
pression of GFP with a CMV promoter was found 1 daycampus, or thalamus, even when the virus was injected
after inoculation, but GFP expression increased overalong the electrode track as the needle was retracted
the next few days. To determine if rAAV would expressfrom the brain (Figure 2G). The longest interval studied
for long periods in the CNS, we studied expression upafter inoculation with rAAV-MCH was 3 weeks, and
to 14 months after brain inoculation and found strongbright positive cells were found. GFP expression was
expression in all injected brain regions, including cortex,greater 6 days after inoculation than after shorter peri-
hippocampus, thalamus, and hypothalamus (Figures 3Fods. GFP-expressing cells were found within 500 to
and 3G). Expression was found in cells with the morphol-600 m of the injection site, as identified by the nee-
ogy of neurons and glia. GFP expression at 1 year postin-dle track.
oculation appeared as strong as that found 1 week afterSimilar results were found after the inoculation of
inoculation; the labeled cells looked healthy, and longmouse brains (n  52) with rAAV-MCH. Expression of
axons arising from GFP-expressing cells could be fol-GFP was restricted to the region of the brain where MCH
lowed to their terminals.neurons have been described. As with the rat, neurons
As a further control, we also examined expressionoutside the MCH region of the brain showed no GFP,
in human astrocytes (109 AAV/ml culture medium). Asand positive cells were not found in the injection needle
expected, no positive GFP expression was found withtrack in the cortex, hippocampus, or thalamus, sug-
the rAAV-MCH. In contrast, rAAV-CMV showed robustgesting selective expression with rAAV-MCH. Immuno-
expression of GFP in human astrocytes (data notstaining with MCH antisera showed that GFP expression
shown), demonstrating that this rAAV has potential forwas found only in neurons that also showed positive
immunostaining with MCH peptide antisera (Figures 3A transgene expression in primates, including humans.
Figure 1. Cartoon and Micrographs Showing Recombinant AAV-MCH Generation and Use
(A) A plasmid containing the MCH promoter driving GFP between a pair of AAV internal terminal repeat sequences is stably transfected in
HeLa cells. The HeLa cell line is then infected with adenovirus, and the resultant replication-incompetent AAV is purified, quantified, and
inoculated into the brain. Brain slices are cut, and GFP-expressing MCH cells are recorded.
(B) Lateral hypothalamic cells of rat were infected in vivo with AAV-MCH. Three green cell bodies and their associated dendrites and fine
processes with an axonal morphology show strong green GFP expression in this section.
(C) Confocal scanning laser microscopy was used to record 12 1 m thick optical sections, which were then collapsed on the z axis. After
AAV-MCH infection, GFP expression in cells and their processes is detected as green fluorescence. Scale bar, 7 m.
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Figure 2. In Vivo Infection with rAAV-MCH Selectively Expresses GFP in Rat MCH Neurons
(A) GFP expression is shown in the rat LH after in vivo infection with AAV-MCH. Arrows indicate three cells.
(B) The same three cells (arrows) shown in (A) are shown in this figure, where antisera reveal immunoreactive MCH in the same neurons that
express GFP. Scale bar, 40 m.
(C and D) The same three cells shown in (A) and (B) are depicted at higher magnification. Scale bar, 18 m.
(E) Neurons express GFP after inoculation with AAV-MCH.
(F) In the same field, there is no overlap in neurons showing hypocretin immunoreactivity. Scale bar, 35 m.
(G) No expression of GFP is seen in the thalamus, even in a section adjacent to the injection track. Scale bar, 30 m.
Membrane Properties CMV showed different membrane properties. Many of
these control cells showed higher spike frequenciesA general characteristic of GFP-expressing MCH cells
was a relatively low level of activity (Figure 4A1). Many (range, 0–6.1 Hz; mean, 1.7  0.4 Hz; n  23) and had
a resting membrane potential slightly positive to theMCH cells showed few or no spikes (Figure 4A3; range,
0–0.8 Hz; mean, 0.15 0.1 Hz; n 23) and had a resting MCH neurons (59.4 1.4 mV; n 23). As the data from
control neurons infected with AAV-CMV were differentmembrane potential of about 61.3  0.9 mV (n  23).
One characteristic of MCH neuron spikes was afterhy- from those from the MCH neurons identified with AAV-
MCH, the characteristics of the MCH neurons are un-perpolarization (AHP), a negative shift of the membrane
potential following the spike (Figure 4A2). The mean likely to represent an artifact due to either AAV infection
or GFP expression.amplitude of the AHP was 12.3  1.9 mV. In contrast,
other hypothalamic neurons used as controls that Spontaneous spikes were either infrequent (Figure
4A1) or absent (Figure 4A3) in MCH neurons. To deter-showed GFP expression after inoculation with rAAV-
Physiology of Virally Identified MCH Neurons
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Figure 3. Comparison of rAAV-MCH and AAV-CMV in the Mouse Brain
(A) In the mouse brain, AAV-MCH labels several neurons; two are indicated by arrows. (B) MCH immunoreactivity colocalizes with the virus-
induced GFP expression. The arrowhead indicates an immunoreactive MCH neuron showing no GFP expression. Scale bar, 15 m. (C) In the
cerebral cortex, AAV-CMV shows expression in a number of cells. Scale bar, 80 m. (D) Neurons and their processes express GFP in the
thalamus (scale bar, 10 m) and (E) hippocampal dentate gyrus (scale bar, 20 m). (F) In the ventrobasal hypothalamus, 6 months after AAV-
CMV viral infection, neurons continue to express GFP. Scale bar, 15 m. (G) In the hippocampus, cells with the morphological attributes of
astrocytes show GFP expression 6 months after in vivo inoculation with AAV-CMV. Scale bar, 30 m.
mine the effect of a command current injection on action 4B2). In contrast, green non-MCH control neurons in-
fected with the control AAV-CMV showed a much higherpotentials, we examined the effect of long (3 s) square-
wave pulses of 40 and 120 pA. Current injection caused spontaneous spike frequency (Figures 4C1 and 4C2),
and, with current injection of similar amplitude, many ofall MCH neurons to fire action potentials. MCH neurons
showed significant spike frequency adaptation, with the the non-MCH cells showed relatively little spike fre-
quency adaptation. In control neurons, interspike inter-last spikes showing a greater interspike interval than
the first of the series (the interspike interval increased vals increased by 2.4%  0.8% when the early phase
of current injection was compared to the late phaseby 78.4%  29.8% when the first and second halves of
a series of spikes were compared; n  6; Figure 4B1). of current injection, a nonsignificant spike frequency
adaptation (n  5) (Figures 4D1 and 4D2). Current injec-In addition, MCH neurons were difficult to drive to high-
frequency bursts or to a large number of spikes with a tion of 120 pA did not elicit spike failure in control neu-
rons (Figure 4D2).long-lasting square pulse (Figure 4B2). Spike failure was
found at 120 pA current injection in MCH neurons (Figure Although a single long-lasting current injection failed
Neuron
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Figure 4. Membrane Properties of MCH Neurons
(A1) Spontaneous spikes under resting conditions (RMP, 58.7 mV) of MCH cells infected with rAAV-MCH. (A2) Note AHP. (A3) Typical silent
MCH neuron (RMP, 62.8 mV).
(B1 and B2) Voltage responses to depolarizing 40 and 120 pA current. Spike frequency adaptation (B1) and spike failure (B2) were characteristic.
(C1 and C2) Spontaneous firing in control cells infected with rAAV-CMV. Most control neurons showed higher regular (C1) or irregular (C2)
spontaneous firing at rest (RMP, 58.4 mV and 60.7 mV for [C1] and [C2]).
(D1 and D2) Voltage responses of control neurons to depolarizing (40 and 120 pA) current. Most control cells showed little spike frequency
adaptation (D1) and no spike failure (D2) under these conditions.
(E) All MCH neurons that were tested could fire at 100 Hz with brief repeated current injections (600 pA, 1 ms at 9 ms intervals; n  6; bottom).
TTX (0.5 M) blocked spikes, which recovered after washout.
(F) Mean current-voltage relationship in 23 MCH neurons.
(G) These three-dimensional graphs show some of the basic membrane properties of the MCH neurons, including spike frequency (y axis),
input resistance (x axis), and membrane potential (z axis) in MCH (upper graph) and control (lower graph) neurons.
to generate high frequencies of spikes, current injec- a series of constant current pulses (from 80 to 40
pA for 200 ms, with a 20 pA increment, at 1 s intervals)tions at short intervals were capable of driving high
frequencies of spikes. All MCH neurons tested could were injected to the recorded neuron, held at resting
membrane potential with 0.5 M TTX, 30 M bicucullinefollow 100 Hz (600 pA for 1 ms, at interstimulus intervals
of 9 ms) current injections (Figure 4E); these spikes were methiodide (BIC), 10 M 6-cyano-7-nitroquinoxaline-
2,3-dione (CNQX), and 50 M dl-2-amino-5-phospono-reversibly blocked by tetrodotoxin (TTX) (0.5 M).
To assess current-voltage relations in MCH neurons, valeric acid (AP5) in the bath; these concentrations of
Physiology of Virally Identified MCH Neurons
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antagonists were used in the experiments below. The
I-V curve appeared to be linear (Figure 4F). MCH cells
showed an input resistance of 423  19 M.
We used a three-dimensional analysis to compare
MCH (n  23) with control (n  23) neurons in terms of
spike frequency, input resistance, and membrane po-
tential. MCH neurons appeared to be fairly homoge-
neous, whereas control neurons from the same region
of the hypothalamus showed considerably greater het-
erogeneity (Figure 4G).
To corroborate further that the physiological data that
were recorded from MCH neurons that were identified
with AAV-MCH were not altered by AAV infection, we
also recorded MCH neurons from transgenic mice that
we raised in which GFP expression was selectively ex-
pressed in MCH neurons. Spike frequency was very low,
0.13  0.1 Hz (n  12), in slices from these transgenic
mice, almost identical to the 0.15 Hz spontaneous spike
frequency described above in AAV-MCH-identified neu-
rons. Similarly, input resistance, spike threshold, and
spike frequency adaptation recorded in MCH-GFP-
transgenic mouse slices were similar to those recorded
from MCH neurons that were identified with the AAV,
and no difference was found between MCH neurons
identified with the two approaches. The experiments
below are based on MCH neurons identified with the
AAV-MCH vector.
Amino Acid Transmitter Responses
All MCH neurons tested (n 23) responded to flow pipe
application of glutamate and to the agonists AMPA and
N-methyl-d-aspartate (NMDA) (n  5) with membrane
depolarization and a burst of spikes in the presence of
glutamate, AMPA, and NMDA (Figures 5A–5C). In volt-
age clamp (60 mV HP), robust inward currents were
generated. Inward currents, 150.2  38.2, 324  98.1,
and 125  36.2 pA, were evoked by glutamate (50 M),
AMPA (30 M), and NMDA (50 M), respectively. MCH
neurons also showed an excitatory response to extracel-
lular adenosine-5-triphosphate (ATP) (Figure 5D). Under
current clamp, 10 M ATP depolarized the membrane
potential of the MCH neurons by 5.9  2.1 mV (n  6).
5-aminomethyl-3-hydroxyisoxazole (muscimol) (30 M),
a GABA-A receptor agonist, attenuated spike frequency
and hyperpolarized the membrane potential by 11.6 
4.3 mV (n  6; Figure 5E).
Both excitatory and inhibitory synaptic activity was
found in MCH neurons. Using a recording pipette with
KMeSO4 and BIC in the bath, EPSCs were identified.
These were blocked by AP5 and CNQX and recovered
after antagonist washout (n  6; Figure 5F). In the pres-
ence of AP5 and CNQX, BIC-blockable inward PSCs
were recorded using KCl in the pipette (n  5; Figure
5G). MCH neurons received a robust GABA-mediated
input, shown by high levels of GABA-mediated synaptic
Figure 5. Fast-Acting Transmitter Responses
(A–C) Responses of three MCH neurons to glutamate (50 M; RMP, case, to determine the effect of muscimol on spikes, a constant
62.3 mV), AMPA (30 M; RMP, 59.9 mV), and NMDA (50 M; level of current sufficient to induce firing was used.
RMP, 64.8 mV), respectively. (F) Representative traces showing the suppressing effect of the
(D) ATP (10 M; RMP, 60.2 mV) also excited MCH neurons. glutamate receptor antagonists CNQX (10 M) and AP5 (50 M) on
(E) The GABA-A receptor agonist muscimol (30 M; RMP, 55.0 mV) spontaneous EPSCs. BIC (30 M) in all solutions.
hyperpolarized the membrane potential and blocked spikes. In this (G) BIC completely suppressed the IPSCs.
Neuron
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activity and by a current (12  3.6 pA) that develops tial shifted as predicted by the Nernst equation for a K
conductance (Figures 6E and 6F). When the externalin BIC. Blocking GABA-A receptors did not increase
spontaneous spike frequency. K concentration was increased to 15 or 30 mM, the
application of 20 M NE resulted in an enhanced inward
current, which reversed at 59  1.9 (n  5; NernstNorepinephrine Inhibits MCH Neurons
prediction,61.1 mV) and36.1 3.8 mV, respectivelyIn current clamp, the arousal-enhancing transmitter nor-
(n  5; Nernst prediction, 42.2 mV) (Figure 6F). In theepinephrine (100 M) reduced spike frequency and hy-
presence of Ba2, NE did not alter the current responsesperpolarized the membrane potential of active MCH
to voltage ramps (Figure 6G, black trace). The nonhydro-neurons (Figure 6A). In TTX, NE evoked a hyperpolarizing
lyzable GDP analog GDPS in the pipette also blockedshift in the membrane potential that recovered after NE
NE effects on currents in response to voltage rampswashout (Figure 6B, trace 1). The mean membrane po-
(Figure 6G, blue trace; n  6). Together, these resultstentials of MCH neurons were66.4 1.5,73.3 2.5,
are consistent with the view that NE activates GIRKand66.7 0.7 mV in control, 100 M NE, and recovery
currents in MCH neurons.conditions, respectively (n  5; p 	 0.05; ANOVA). The
If NE acted through an 
-2 adrenoreceptor to activateNE effects on membrane potential were dose depen-
a GIRK-like current, then the agonist clonidine shoulddent; 1, 20, and 400 M NE hyperpolarized the mem-
generate the same effect as NE. We evaluated the effectbrane potential by 1.8  0.4, 5.3  2.0, and 9.7  1.8
of 200 nM clonidine on the currents generated with volt-mV, respectively.
age-ramp commands from 140 to 10 mV, under theHyperpolarizing Actions of NE Are Mediated
same conditions described above (in TTX, Cd2, AP5,by an -2 Adrenoreceptor
CNQX, BIC). Clonidine (200 nM) evoked an inwardly rec-To determine the receptor subtype involved in this inhi-
tifying current, reversing at 68.2  3.12 mV with 15bition, the actions of NE were first evaluated in the pres-
mM bath K, close to the value predicted by the Nernstence of idazoxan (0.1–1 M), a selective 
-2 adrenore-
equation (Figure 6H, blue trace; n  4). The currentceptor antagonist. All of the experiments were done in
saturated at more negative potentials and was blockedcurrent clamp with TTX, AP5, CNQX, and BIC. In the
by barium (800 M). When NE was tested in the samepresence of idazoxan (100 nM), NE (20 M) did not alter
group of cells, a similar current was detected (Figurethe membrane potential (Figure 6B, trace 2, and Figure
6H, red trace). After the 
-2 adrenoreceptors were6C; n  6; p  0.86; ANOVA), suggesting that the NE-
blocked with idazoxan (100 nM), the NE actions on theinduced hyperpolarization was mediated by the 
-2 ad-
GIRK current were abolished (n  5; Figure 6H).renoreceptor subtype activation. Clonidine, a selective
NE Modulates Synaptic Inputs to MCH Neurons
-2 receptor agonist, induced a robust hyperpolarizing
Next, we evaluated NE actions on the synaptic inputsshift in the membrane potential in six of six cells tested
to MCH neurons. Holding the cells at 70 mV with(Figure 6B, trace 3, and Figure 6C). Both the time course
KMeSO4 in the pipette, NE (20 M) induced a fast de-and the magnitude of the clonidine-induced hyperpolar-
crease in the frequency of the AP5/CNQX-sensitiveization were similar to the NE effect described above
EPSCs (n 5; Figures 6I1 and 6I2). The EPSC frequency(Figure 6B, traces 1 and 3). Clonidine hyperpolarized the
decreased by 62.5%  5.0% compared to the controlmembrane potential by 5.9 0.6 mV (p	 0.05; ANOVA).
level (Figures 6I1–6I3) and recovered after NE washoutIn contrast, the 
-1 agonist phenylephrine (100 M)
(n  5; p 	 0.05; ANOVA).evoked no significant change in the membrane potential
Outward currents were detected when the cells were(Figure 6B, trace 5, and Figure 6C; n  4; p  0.87;
held at 40 mV (Figure 6J1). NE (20 M) induced aANOVA). The 
-1 antagonist prazosin (1 M) did not
robust increase in the frequency of these outward PSCsblock NE actions (Figure 6B, trace 4, and Figure 6C);
(Figures 6J1–6J3). The NE actions on the outward cur-NE application in the presence of prazosin resulted in
rents were a little slower than its actions on the inwarda hyperpolarization of 6.6  0.8 mV (n  4; p 	 0.05;
PSCs. NE increased the frequency of BIC-blockable out-ANOVA).
ward PSCs by 141%  7% compared to control pre-NE Modulates GIRK Currents
NE levels (Figure 6J3). This effect was reversible andVoltage-ramp commands (700 ms) from 140 to 10
statistically significant (n  4; p 	 0.05; ANOVA).mV were used with AP5, CNQX, and BIC. Voltage-depen-
dent Na and Ca2 currents were eliminated by TTX and
Cd2 (200 M), respectively. With normal K concentra- Acetylcholine and Serotonin Receptor Agonists
Depress MCH Neuronstion in the bath (3.3 mM K), 20 M NE application
resulted in the activation of a robust current in four MCH Two transmitters found in the LH that are postulated to
enhance arousal states are acetylcholine and serotonincells that were tested (Figure 6D). The reversal potential
for the NE-induced current was 98.4  2.4 mV (Figure (Mochizuki and Scammell, 2003). The metabotropic ace-
tylcholine receptor agonist-muscarine chloride (mus-6E, black trace, and Figure 6F), which approximates
the K equilibrium potential predicted by the Nernst carine) (100 M) reduced spike frequency in current
clamp (Figure 7A1), and in the absence or presence ofequation (102 mV; Ki  145 mM; Ko  3.3 mM). We
further evaluated the K dependence of the NE-induced TTX, it had a hyperpolarizing effect on the membrane
potential (Figure 7A2). We evaluated the dose-depen-current by increasing external K to 15 mM (Figure 6E,
red trace) and 30 mM (Figure 6E, blue trace), with KCl dent effect of muscarine on the membrane potential in
MCH neurons in TTX, AP5, CNQX, and BIC. Substantialsubstituted for an equimolar amount of NaCl. As external
K increased, the inward component of the NE-induced hyperpolarization was observed by muscarine at a con-
centration of 10 M or more. Muscarine (10, 100, andcurrent increased dramatically, and the reversal poten-
Physiology of Virally Identified MCH Neurons
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Figure 6. Norepinephrine Depresses MCH Neurons by Direct and Indirect Mechanisms
(A) Norepinephrine (100M) (NE) hyperpolarized the membrane potential and abolished the spontaneous firing of MCH neurons. RMP,62.2 mV.
(B) The hyperpolarizing actions of NE were mediated by 
-2 adrenoreceptor activation. All the experiments in TTX, AP5, CNQX, and BIC were
under current clamp. Trace 1: NE (20 M) depressing actions on the membrane potential of a MCH neuron. Trace 2: In idazoxan (Ida; 100
nM), NE (20 M) failed to hyperpolarize MCH neurons. Trace 3: Clonidine (Clon; 200 nM) emulated the NE actions on membrane potential. Trace
4: Prazosin (Praz; 1 M) has no effect on NE-induced hyperpolarization. Trace 5: Phenylephrine (Phen; 10 M) did not alter membrane potential.
(C) Bar graph showing the alteration in the membrane potential of MCH neurons after application of 
-1 and 
-2 adrenoreceptor agonists
and antagonists.
(D) In voltage clamp with a voltage-ramp command, NE induced a robust current shift.
(E and F) Increases in extracellular K (from 3.3 to 15 or 30 mM) shifted the reversal potential of the NE-induced current, in accordance with
the Nernst prediction for a K conductance (black line in [F]).
(G) The NE-induced current was abolished by extracellular barium (800 M) and GDPS in the pipette.
(H) In idazoxan (100 nM), NE failed to activate a K current. Clonidine (200 nM) mimicked the NE-induced K current.
(I1–I3) NE decreased EPSC frequency.
(J1–J3) NE increased the frequency of IPSCs.
500 uM) hyperpolarized MCH neurons by 1.4  0.3, membrane potential in the four cells that were tested
(data not shown).4.5  0.4, and 7.45  0.8 mV, respectively (Figure 7A4).
Muscarine (100 nM) had no detectable effect on the To study muscarinic actions on synaptic inputs to
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Figure 7. Muscarine and Serotonin Inhibit MCH Neurons
(A1) Muscarine (100 M) suppressed the firing rate of MCH neurons. RMP, 61.7 mV. (A2) In TTX, muscarine hyperpolarized the membrane
potential. (A4) The muscarine effect on the membrane potential was dose dependent (10–500 M). (A3, A5, and A6) Muscarine enhanced the
synaptic input (A3 and A5). Muscarine increased mPSC frequency (A6).
(B1) Serotonin (100 M) (5HT) inhibited spikes. RMP, 62.3 mV. (B2) In TTX, 5HT hyperpolarized MCH cells. (B4) The 5HT effect was dose
dependent (10–500 M). (B3 and B5) 5HT did not alter the frequency of the PSCs. No effect of 5HT on the frequency of mPSCs in TTX was
found, suggesting the absence of presynaptic modulation by 5HT.
MCH neurons, voltage clamp was used (60 mV HP) NPY Inhibits MCH Neurons
In MCH neurons that showed spontaneous spikes, NPYwith KeMSO4 in the pipette. Muscarine induced a revers-
ible increase in the frequency of PSCs in MCH neurons (1 M) inhibited the spike frequency and hyperpolarized
the membrane potential (n  4) (Figure 8A). Similarly, in(Figure 7A3). PSC frequency was increased by 202% 
40% by muscarine (Figure 7A5) (n 5; p	 0.05; ANOVA). normally silent MCH neurons that were driven to spike
by current injections that were just above the spikeThe increase in the PSC frequency might be explained
by direct muscarine actions on presynaptic axons in- threshold, NPY blocked the evoked spikes (n 5; Figure
8B). In TTX, NPY hyperpolarized the membrane potentialnervating MCH neurons or by activation of muscarinic
receptors in the somatodendritic region of local in- (Figures 8C and 8D) by 7 2.1 mV (Figure 8D) (p	 0.05;
ANOVA; n  5).terneurons that were in synaptic contact with MCH cells.
Muscarine (100 M) caused a reversible increase in the To further identify the mechanisms underlying the
NPY-mediated hyperpolarization, we first evaluated itsfrequency of the miniature PSCs (mPSCs) (Figure 7A6).
mPSC frequency increased by 52.5%  4.9% (n  4; actions on the current-voltage relation in current clamp
in TTX, AP5, CNQX, and BIC. I-V relations were signifi-p 	 0.05; ANOVA). Because the postsynaptic effect (in
TTX) of muscarine was hyperpolarization, a postsynap- cantly altered by the application of NPY (n  4; p 	
0.05; ANOVA). NPY increased the membrane conduc-tic mechanism may not explain the increase in mPSCs.
Together, our results support the view that the acetyl- tance from 2.5  0.1 to 3.2  0.1 nS (Figure 8E; n 
6; p 	 0.05; ANOVA), returning to 2.5  0.1 nS aftercholine receptor agonist muscarine depresses MCH
neurons by direct actions on the cell body but increases NPY washout.
The hyperpolarizing actions of NPY, as well as itsthe activity of the presynaptic axons.
Similar to NE and muscarine, 5HT hyperpolarized six effects on the membrane conductance, led to the hy-
pothesis that the activation of the NPY receptors couldof six neurons. Two of the neurons showed spontaneous
spikes, and these spikes were blocked by 5HT (Figure enhance a K current. To address this issue, voltage-
ramp commands from 140 to 10 mV (for 700 ms)7B1). A 5HT-mediated hyperpolarization in TTX was
noted (Figure 7B2; p 	 0.05), with partial recovery (n  were used (top of Figure 8F), and the current responses
in the presence and the absence of NPY were compared5; p 0.05; ANOVA). The 5HT actions on the membrane
potential were dose dependent (Figure 7B4). In voltage in TTX, Cd2 (200 M), AP5, CNQX, and BIC. In a normal
3.3 mM K bath, NPY increased the current responseclamp, in the presence or absence of TTX, 5HT had no
significant effect on mPSC or PSC frequency (Figures compared to the control (pre-NPY) condition (Figure 8F).
When control was subtracted from the NPY current, the7B3, 7B5, and 7B6; n 6 in each case; p0.05; ANOVA).
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Figure 8. Neuropeptide Y Inhibits MCH Neurons
(A) NPY (1 M) blocked spontaneous spikes and hyperpolarized the membrane potential. RMP, 62.7 mV.
(B) NPY (1 M) depressed evoked action potentials in silent MCH neurons. Action potentials were evoked by the application of spike threshold
square-current injection (40 pA for 100 ms at 1 s intervals). RMP, 64.7 mV.
(C) In the presence of TTX in the bath, NPY hyperpolarized the membrane potential. RMP, 63.3 mV.
(D) Bar graph showing the mean NPY-induced hyperpolarization (n  5; p 	 0.05; ANOVA).
(E) NPY (1 M) increased the membrane conductance of six MCH neurons (p 	 0.05; ANOVA).
(F) When voltage-ramp commands were delivered to the MCH cells, NPY (1 M) application caused a shift in the current response. The
stimulation protocol is shown in the upper part of (F).
(G) The NPY-induced current reversed at 107.4  5.7 and 67.4  3.2 mV in normal (3.3 mM; thicker trace) and 15 mM (thinner trace)
extracellular K concentration, respectively. In the presence of Ba2 (800 M), both NPY currents were lost (gray trace). These results suggest
that NPY activated a K current in the MCH cells.
(H1–H3) Under voltage clamp, with BIC in the bath, 60 mV HP, and KMeSO4 in the pipette, NPY (1 M) depressed EPSC frequency. AP5
and CNQX completely abolished the EPSCs (last trace, [H1]).
(I1–I3) Using KCl in the pipette and AP5 and CNQX in the bath, NPY (1 M) decreased IPSC frequency. The inhibitory activity was blocked
by BIC (last trace, [I1]).
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net current was obtained (Figure 8G, thicker black trace). Hypocretin Excites MCH Neurons
A hypothalamic modulator that plays a key role in theUnder normal (3.3 mM) extracellular K concentrations,
control of arousal is hypocretin/orexin. Hypocretin re-the NPY-induced current reversed at 107.4  5.7 mV
ceptors are expressed in the LH area (Marcus et al.,(n  4), consistent with activation of a K conductance.
2001). Hypocretin-1 and -2 evoked a consistent long-When extracellular K was increased to 15 mM (with
lasting membrane depolarization and an increase inKCl substituted for an equimolar amount of NaCl), the
spikes in normally silent MCH cells (n  5; Figure 9A).inward component of the NPY-induced current in-
Hypocretin-2 (Hcrt-2) alone (1 M) evoked a membranecreased in size, and the reversal potential shifted
depolarization and spike burst (Figure 9B). In TTX, Hcrt-2to 67.4  3.2 mV, consistent with a shift in the K
reversibly depolarized the membrane potential fromequilibrium potential predicted by the Nernst equation
61.2  0.7 to 52.8  2.1 mV (n  5) (Figure 9H). In(Figure 8G, thinner black trace). Both the inward and
voltage clamp, Hcrt-2 evoked a robust inward current,the outward components of the NPY-evoked current
both in the absence and presence of TTX (20.4  5.6were abolished with barium in the bath (Figure 8G).
pA in TTX) (Figures 9C and 9D). Hypocretin-1 (Hcrt-1)GDPS in the pipette blocked NPY-mediated K cur-
depolarized MCH neurons by 7.3  2.1 mV (n  4).rents (n  5).
In BIC, Hcrt-2 (1 M) reversibly increased AP5/CNQX-NPY reversibly depressed the AP5/CNQX-blockable
blockable EPSC frequency by 145%  66.3% (FiguresEPSC frequency (Figures 8H1–8H3), returning to control
9E–9G). Together, these data indicate that hypocretinlevels 10–15 min after washout (Figures 8H1–8H3). NPY
excites MCH neurons by depolarizing actions on the cell(1 M) reduced the EPSC frequency by 26.5%  2.1%
body and by enhancement of glutamate release onto(n 4; p	 0.05; ANOVA). NPY reduced IPSC frequency
MCH cells.(Figure 8I1), with partial recovery 15 min after peptide
We used immunocytochemistry to study contacts be-washout (Figure 8I2). The frequency of BIC-sensitive
tween the closely interspersed hypocretin and MCHIPSCs was reduced by 37.9%  7.6% (Figures 8I1 and
cells (Figure 9I). Numerous small, green, hypocretin-8I3; n  6; p 	 0.05; ANOVA). NPY reduced mIPSC
immunoreactive boutons contacted the cell body of or-frequency by 32.1%  7.6% (n  6; p 	 0.05; ANOVA),
ange-immunostained MCH neurons (Figure 9J). Some
with no change in the cumulative mIPSC amplitude dis-
MCH neurons were found that appeared to be contacted
tribution (p  0.05; Kolmogorov-Smirnov test), sug-
by up to 30 individual hypocretin-positive boutons; other
gesting that NPY mediated presynaptic inhibition of
cells had no detectable hypocretin-immunoreactive
transmitter release. boutons on MCH perikarya. In addition, orange MCH-
immunoreactive boutons were found in apparent con-
tact with hypocretin neurons and their proximal den-
Melanocortin Receptors and MCH Neurons drites (Figures 9K and 9L).
Arcuate nucleus POMC neurons may release 
-MSH,
which in turn depresses feeding; if these peptides do so Discussion
by influencing the MCH neuron, then one would expect
melanocortin receptor agonists to depress the activity In the present paper, using a recombinant AAV that
of MCH neurons. The melanocortin receptor agonist (Ac- expresses GFP selectively in hypothalamic MCH neu-
Nle4, Asp5, D-Phe7, Lys10)-cyclo-
-MSH(4-10)-amide (MTII) rons, we employed whole-cell recording to study the
(1M) evoked no detectable effect on membrane poten- membrane characteristics, GABA and glutamate synap-
tial or firing rate (n  5; p  0.78; ANOVA). Using the tic activity, and transmitter responses of these identified
same agonist, Liu et al. (2003) reported a membrane neurons. MCH neurons as a group were different than
depolarization and increase in spike frequency in the other nearby neurons, particularly in their low frequency
neurons of the dorsomedial and paraventricular nuclei of spontaneous spikes. The orexigenic peptide NPY was
in transgenic mice that expressed GFP in MC4 receptor- inhibitory, whereas anorexigenic melanocortin agonists
positive neurons. MTII caused no detectable change in or antagonists had no effect. Neuromodulators of extra-
the frequency of the PSCs. The normalized PSC fre- hypothalamic arousal systems, including NE, 5HT, and
quency was 100%, 105.1% 3.5%, and 103.2% 5.4% ACh (muscarine), inhibited MCH neurons. Hypocretin, a
in control, MTII (1 M), and recovery conditions, respec- neuropeptide involved in arousal, evoked a substantive
tively (n  5; p  0.82; ANOVA). depolarization, inward current, and robust increase in
To test if MCH cells might be influenced by endoge- action potentials. Together, these data support the view
nous release of melanocortins in the slice, we added that the MCH neurons may be integrated into the hypo-
the melanocortin antagonist (Ac-Nle4, Asp5, D-2-Nal7, thalamic arousal system, but do not support the view
Lys10)-cyclo-
-MSH(4-10)-amide (SHU9119), which may that the orexigenic nature of MCH neurons is due to
mimic the effect of the endogenous melanocortin recep- direct responses to mediobasal hypothalamic feeding
tor antagonist agouti-related protein (Cowley et al., peptides.
1999). No change in the membrane potential or spike
frequency was detected with SHU9119 (n 5; p 0.81; Characterization of MCH Neurons
ANOVA). SHU9119 (1 M) did not alter the frequency of Similar to the nearby hypocretin neurons (Li et al., 2002),
the spontaneous PSCs in MCH cells (n  6; p  0.88; excitatory synaptic input to MCH cells was due to gluta-
ANOVA), suggesting that this melanocortin receptor an- mate release, and inhibitory activity was due to GABA
tagonist did not modulate the synaptic input to MCH release. MCH neurons showed a very low level of spon-
taneous spikes in MCH-GFP-transgenic mice and incells.
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Figure 9. Hypocretin/Orexin Induces Strong Direct and Indirect Excitation of MCH Neurons
(A) The addition of a solution containing both Hcrt-1 and -2 (1 M each) depolarized and increased the spike frequency of MCH neurons.
RMP, 60.1 mV. (B) Hcrt-2 (1 M) by itself also induced a depolarization and increase in the firing rate. RMP, 61.5 mV. (C) Held at 60 mV,
Hcrt-2 evoked a robust inward current. (D) The Hcrt-2-induced inward current persisted in TTX. HP, 60 mV. (H) Bar graph showing the mean
depolarizing effect of Hcrt-2 on the membrane potential (n  5; p 	 0.05; ANOVA). (E) Traces show the excitatory effect of Hcrt-2 (1 M) on
EPSC frequency. (F) Time course of the Hcrt-2 effect on EPSCs. (G) Bar graph shows the mean effect of Hcrt-2 on EPSC frequency (n  3).
(I) In the mouse LH, MCH neurons (orange) and hypocretin neurons (green) are found closely interposed. (J) Two orange MCH-immunoreactive
neurons are contacted by small, green boutons from hypocretin-immunoreactive axons. (K and L) Green hypocretin neurons and their proximal
dendrites are contacted by numerous boutons immunoreactive for MCH. Scale bars, 12 m (I), 4 m (J–L).
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AAV-MCH-inoculated mouse cells in the present study MCH Neurons as Part of a Conditional
Arousal Systemand in rat cells detected with post hoc immunostaining
The widespread axonal projections of the MCH neurons(Eggermann et al., 2003); even when GABA receptors
(Bittencourt et al., 1992) and the similarly widespreadwere blocked, MCH neurons showed no increase in
expression of the MCH receptor (Chambers et al., 1999;spike frequency, suggesting that the low level of activity
Saito et al., 1999) suggest that MCH neurons may bewas in part an intrinsic feature of the cells. This contrasts
involved in some type of global CNS activation or inacti-with the adjacent hypocretin neurons, which show con-
vation.tinuous spike frequencies of 2–4 Hz (Li et al., 2002).
The functions of MCH neurons appear to be quiteAnother difference between MCH and hypocretin neu-
complex and include the modulation of food intake de-rons is that MCH cells show striking spike frequency
scribed above, in addition to sleep and arousal, anxiety,adaptation, whereas hypocretin cells do not. In addition
locomotor activity, and memory (Borowsky et al., 2002;to responding to the ionotropic glutamate receptor ago-
Verret et al., 2003). MCH receptors and axons are foundnists AMPA and NMDA, MCH cells also showed a rapid
in high densities in the same regions of the brain thatincrease in activity in response to extracellular ATP,
show the highest metabolic activity generated by re-suggesting that the cells express excitatory gluta-
warding electrical stimuli of the LH (Valenstein andmatergic and purinergic receptors.
Campbell, 1966), suggesting a possible role in reward
and motivation.Neuropeptide Y Inhibits MCH Neurons
Further clues to the function of MCH neurons mayMCH neurons may play a role in energy homeostasis,
arise from an examination of their transmitter responses,based on findings that MCH administration increases
as described in our experiments. Neurons that releasefeeding, that MCH peptide or receptor absence de-
NE, 5HT, or ACh have each been postulated to partici-creases feeding and body weight, and that MCH neu-
pate in arousal (Mochizuki and Scammell, 2003). Eachrons show changes in mRNA synthesis during starvation
of these neuromodulators, depending on the receptor(Qu et al., 1996; Shimada et al., 1998; Marsh et al., 2002).
expressed, could exert excitatory or inhibitory actions.Similarly, NPY intracranial injections increase feeding.
Interestingly, all three—NE, 5HT, and the ACh agonistIn addition, the MCH neurons are contacted by NPY
muscarine—exerted robust inhibitory actions on MCHimmunoreactive boutons (Elias et al., 1998; Broberger
neurons, and, as membrane hyperpolarization was seenet al., 1998). This has led to the hypothesis that NPY
even in TTX, the actions were due to direct effects onneurons may act to enhance feeding by exciting MCH
the MCH cell. The strongest effect was generated byneurons (Schwartz et al., 2000; Schwartz and Gelling,
NE, and multiple mechanisms of inhibition were found.2002). In contrast, our data show that NPY consistently
One was based on activation of an 
-2 type adrenore-exerts inhibitory actions on MCH neurons similar to the
ceptor in the presence of NE or clonidine and blockableinhibitory actions of NPY in other regions of the hypo-
by idazoxan. As with NPY, NE appeared to activate athalamus (van den Pol et al., 1996; Rhim et al., 1997).
barium-sensitive G protein-dependent GIRK current.NPY caused a direct hyperpolarization even in the pres-
Similarly, in dispersed hypothalamic cultures, NE
ence of TTX, by a mechanism that was consistent with
showed inhibitory actions (Gao et al., 2003). A second
activation of a GIRK current. In addition, NPY inhibited
mechanism of inhibition was a NE-mediated reduction
synaptic activity in MCH neurons, in part by a presynap-
in glutamatergic EPSCs, and a third was a NE-evoked
tic mechanism whereby NPY reduced transmitter re- increase in IPSCs. All three NE-mediated mechanisms
lease at the axon terminal, as detected by a decrease would depress the activity of MCH neurons.
in frequency, but not amplitude, of mPSCs. The inhibitory responses of MCH neurons to neuro-
NPY has been postulated to exert anxiolytic effects modulators of extrahypothalamic arousal systems are
that are particularly potent when NPY is administered very similar to those recorded in the sleep-promoting
to the posterior hypothalamus near the MCH neurons neurons (Sherin et al., 1996) of the ventrolateral preoptic
(Ehlers et al., 1997; Naveilhan et al., 2001). In parallel, area (Gallopin et al., 2000). Insight into the function of
MCH receptor antagonists are anxiolytic (Borowsky et MCH neurons is provided by several studies examining
al., 2002). Our data showing that NPY depresses MCH the phenotype of transgenic mice in which MCH or its
neuron activity, parallel to actions of MCH receptor an- receptors were disabled. These mice showed a lean
tagonists, suggest that one possible mechanism of NPY body type and, importantly, showed an increased activ-
anxiolytic action may be in depressing the MCH system. ity level and metabolic rate (Shimada et al., 1998; Marsh
The POMC neurons of the arcuate nucleus have been et al., 2002). Crossing an MCH knockout mouse with a
postulated to inhibit feeding, based on activation of the mouse obese due to genetic leptin deficiency caused a
MC3/4 receptor. In our experiments, an MC3/4 receptor reduction of body weight; importantly, the reduction in
agonist and antagonist had no detectable effect on MCH weight was not due to a decrease in hyperphagia but
neurons; this is consistent with the absence of the MC4 was instead due to an increased resting energy expendi-
receptor in MCH neurons (Liu et al., 2003). We also ture and increased behavioral activity (Segal-Lieberman
found no effect of melanocortin receptor agonists or et al., 2003). Recent data suggest that MCH may en-
antagonists on synaptic activity recorded in MCH neu- hance REM sleep (Verret et al., 2003). Together, the
rons. These data suggest that it is unlikely that a direct inhibitory actions of the arousal neuromodulators de-
effect on MCH neurons of either the orexigenic NPY scribed here, coupled with the observations of knockout
neurons or the anorexigenic POMC neurons is the mech- mouse phenotype, are consistent with a view that part
anism whereby the arcuate nucleus regulates feeding of the function of MCH neurons may relate to energy
conservation.behavior.
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The hypocretin neurons intermingled with the MCH orexigenic NPY system and the anorexigenic POMC sys-
neurons (de Lecea et al., 1998; Sakurai et al., 1998) play tem that are postulated to regulate energy homeostasis
a substantial role in arousal. Injections of hypocretin (Schwartz et al., 2000). Perhaps the inhibitory actions
enhance arousal, and loss of hypocretin peptide or its of MCH cells counter and fine-tune the excitatory ac-
receptors results in narcolepsy (Peyron et al., 2000; tions of the hypocretin neurons. This would be consis-
Thannickal et al., 2000; Lin et al., 1999). Although we tent with the classic work showing sensory neglect after
tried a number of different neuromodulators that have LH lesion and recording experiments suggesting that
been postulated to play a role in energy homeostasis or the LH may be involved in general arousal and sensory
arousal, hypocretin stood out in its dramatic excitatory sensitization (Rolls, 1984; Rolls and Kelley, 1972) that
effects on MCH cells. Even MCH neurons that showed is dependent on a combination of environmental and
no spikes under control conditions were excited to fire enteroceptive sensory input relating to state-dependent
strong bursts of spikes in the presence of hypocretin-1 goal-directed behavior. Thus, MCH neurons could hypo-
or -2. The similar or greater response of MCH neurons thetically modulate arousal or goal-directed arousal, de-
to hypocretin-2 compared with hypocretin-1 suggests pendent on the metabolic state and sensory input, similar
that MCH cells express functional hypocretin receptor to the hypocretin neurons (Yamanaka et al., 2003), but
2 (orexin receptor 2), as the hypocretin receptor 1 is with an opposing cellular action.
relatively insensitive to hypocretin-2 (Sakurai et al.,
1998). The idea that hypocretin axons innervate MCH Selective Transgene Expression with AAV Is
cells was supported by our double immunostaining in Determined by Gene Promoter
mice and by previous suggestions, based on immuno- In the present study, after inoculation of the brain in vivo
staining in rats, that hypocretin axons contact or syn- with rAAV-MCH, we found expression of GFP only in a
apse on MCH neurons (Peyron et al., 1998; Elias et al., subpopulation of hypothalamic neurons that showed
1998; Guan et al., 2002). Although we found that hypo- immunoreactivity for MCH. No GFP expression was
cretin enhanced excitatory synaptic input to hypocretin found in the adjacent hypocretin/orexin neurons. No
neurons, no direct excitatory effect of hypocretin was GFP was found in nonneuronal cells or in any cells along
detected on hypocretin neurons (Li et al., 2002). It is the injection track in the cortex, hippocampus, or thala-
therefore striking that the nearby MCH neurons showed mus. As the virus would have no selectivity for infection
a dramatic and direct excitatory response to hypocretin of MCH neurons, the selective expression is due to the
even when spike-mediated synaptic activity had been activation of the MCH promoter only in MCH neurons
blocked with TTX. In addition to the direct action at and not in other cells infected with the virus. No differ-
the cell body, hypocretin further excited MCH neurons ence was found in the membrane properties of MCH
indirectly by enhancing glutamate release from excit- neurons identified by AAV-MCH or identified in trans-
atory axons contacting MCH neurons. genic mice that expressed GFP selectively in MCH neu-
As the hypocretin and MCH neurons have similar rons, consistent with the view that infection with AAV
widespread and often converging projections, the ques- does not alter neuronal physiology (During and Leone,
tion is raised as to whether the two neuron types might 1995).
have similar effects. The hypocretin peptide exerts excit-
atory actions in the hypothalamus (de Lecea et al., 1998;
AAV Gene Transfer into Phenotype-Specific
van den Pol et al., 1998) and in extrahypothalamic tar-
Neurons in the Braingets (Burlet et al., 2002; Liu et al., 2002), and the excit-
Our data show that, under control of the MCH promoter,atory transmitter glutamate colocalizes with hypocretin
GFP is only expressed in MCH neurons, suggesting that(Rosin et al., 2003; Torrealba et al., 2003). In contrast,
the same approach could be used to identify other neu-MCH reduces spike frequency, synaptic activity, and
ronal phenotypes within the brain. An alternate methodcalcium currents in hypothalamic neurons (Gao and van
that we and others have used to identify and recordden Pol, 2001). Single hypothalamic neurons are excited
from select phenotypes of cells is the use of transgenicby hypocretin but depressed by MCH (Gao and van
mice that express GFP under the control of selectiveden Pol, 2001). In addition, the inhibitory amino acid
neuronal promoters (Li et al., 2002; van den Pol andtransmitter GABA is reported to colocalize in MCH neu-
Ghosh, 1998; van den Pol et al., 2002; Cowley et al.,rons (Elias et al., 2001). Together, these data suggest
2001; present paper). A substantial advantage of thethat MCH neurons are inhibitory and would counteract
approach we describe here is that the same virus canthe actions of hypocretin if the two cell types converged
potentially be used to express selectively a gene in aon common postsynaptic targets.
broad spectrum of species, as we demonstrated by us-Given the complexity of the MCH projections and re-
ing AAV-MCH in both the rat and mouse brain and AAV-ceptor patterns and the different functions that have
CMV in human cells. In contrast, the generation of abeen postulated for MCH neurons, as well as their trans-
transgenic animal is limited to the species of gene intro-mitter response profile and presumptive inhibitory ac-
duction. Furthermore, the virus can be frozen with rela-tions, hypothetically, MCH neurons may be part of a
tively little cost for years, whereas maintaining a trans-state-dependent system that fine-tunes arousal and
genic mouse colony is quite expensive. Finally, a newgoal-directed behavior. This may relate to the complex
neuron-selective AAV can be generated in a few weeks;interaction of the LH reward system, which is modulated
generating a breeding colony of transgenic rodentsby energy balance and metabolic signals (Fulton et al.,
takes many weeks of work over the course of several2000). Other aspects of hypothalamic homeostatic regu-
months.lation may be dependent on opposing cell types, for
instance, the opposing actions of the arcuate nucleus A potential limitation of AAV is that the maximum
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isolated following HeLa cell transfection with plasmid pAAV/MCH-packaging size of DNA into recombinant AAV is about
GFP/rep-cap/neotk and subsequent G418 (700 g/ml) drug selec-5 kb, although work with AAV heterodimers suggests
tion. Two hundred individual cell lines were screened following wild-that this can be increased to 10 kb under some circum-
type adenovirus type 5 infection (multiplicity of infection [MOI], 20),
stances (Samulski, 2000). The recombinant AAV is repli- and 1B3 was identified as producing the highest number of DNase-
cation incompetent, an advantage from the perspective resistant particles (DRP) per cell (2.1  104 DRP per cell). For large-
of safety and containment. By generating a cell line that scale vector production, 1.4 1010 1B3 cells were grown in a Corning
Cell Cube adherent cell bioreactor and infected with wild-type ade-contains the necessary viral genes and the transgene
novirus 5 (MOI, 20). Following development of an adenovirus cyto-of interest, it is a simple proposition to generate more
pathic effect (72 hr), rAAV was purified from the crude 1B3 cell lysatevirus directly from the recombinant cells as needed, as
using heparin chromatography as previously detailed (Clark et al.,
shown in Figure 1. 1999). DRP titers were determined for purified rAAV2/MCHV by real-
AAV has eight recognized serotypes, AAV1 through time PCR methodology utilizing a Prism 7700 Taqman sequence
AAV8, that have been reported to differentially infect detector system (PE Applied Biosystems). The primer and fluores-
cent probe set used for rAAV/MCHV quantitation were as follows:various cell types. Considerable energy has been de-
GFP forward primer, 5-CCACTACCTGAGCACCCAGTC-3; GFP re-voted to the determination of which subtype is more
verse primer, 5-TCCAGCAGGACCATGTGATC-3; and probe, 5-likely to infect and express transgenes in neurons and
FAM-TGAGCAAAGACCCCAA CGAGAAGCG-TAMRA-3. Purifiedother cell types. The data here suggest that the promoter
rAAV was carefully tested for adenovirus as described elsewhere
is as important as the serotype. Many studies with AAV (Clark et al., 1999), and no adenovirus was detected. HeLa cells
have employed a CMV promoter, which is advantageous were maintained in DMEM supplemented with 10% fetal bovine
because it leads to rapid and robust expression. With serum (FBS) and penicillin and streptomycin. rAAV2/MCHV stable
producer cells (1B3) were maintained in DMEM, 10% FBS, penicillinthe same viral coat (AAV2), we find selective gene ex-
and streptomycin, and G418 (700 g/ml).pression only in neurons with the MCH promoter, but
Recombinant AAV-MCH was injected with a Hamilton microsy-expression in both neurons and in glia with a viral (ie1
ringe into the hypothalamus of 10- to 18-day-old rats and mice while
CMV) promoter. As cytomegalovirus itself may preferen- the rodents were anesthetized. Solution (500 nl) containing 5  109
tially infect astrocytes (van den Pol et al., 1999), the AAV particles was injected into the left and right hypothalamus.
widespread use of the CMV promoter may not be the From 5 to 14 days later, rodents were anesthetized with ketamine
and xylazine (100 and 10 mg/Kg, respectively), and the brains wereideal way to express transgenes selectively in neurons.
harvested. The use of animals in these experiments was approvedAlthough the focus of the present study is on reporter
by the Yale University Animal Care and Use Committee.gene expression to facilitate the analysis of cellular physi-
For control purposes, we used an AAV that expressed GFP underology of identified cells, the same promoter-directed ex-
the control of the cytomegalovirus ie1 (CMV) promoter, produced
pression of genes may have wider applicability and in a manner similar to that used for AAV-MCH.
could enable selective gene expression in subsets of As an additional tool, an 830 bp mouse MCH promoter was con-
neurons, potentially of use for gene replacement after structed into a promoter-free plasmid, pEGFP-1. A 2 kb fragment
containing the mouse MCH promoter and the GFP gene followedneuron loss in diseases such as Parkinson’s disease or
by the SV40 polyA signal sequence was used to develop transgenicnarcolepsy or to selectively kill brain tumor cells with a
mice, with methods previously described (van den Pol et al., 2002).cell type-selective promoter driving a toxin such as ricin.
In fact, we demonstrate long-term expression (1 year,
Immunocytochemistrythe longest interval tested) in mouse brain and expres- To test whether the recombinant viruses expressed reporter genes
sion in human cells with the same recombinant AAV, only in MCH neurons, we used immunostaining against MCH peptide
suggesting potential applicability from animal models with a rabbit antiserum from Dr. Paul Sawchenko; the specificity of
the antiserum has been described in detail elsewhere (Bittencourtto the human brain.
et al., 1992). Rabbit antiserum against hypocretin/orexin was also
Experimental Procedures used; the specificity of this antiserum has been described previously
(van den Pol et al., 1998; van den Pol, 1999). Both antisera were
Construction of a rAAV2 Plasmid Containing the MCH used at concentrations of 1:5000 and detected with a secondary
Promoter and Enhanced GFP Gene for rAAV2/MCHV Production donkey or goat anti-rabbit immunoglobulin conjugated to Texas
To generate the MCH promoter-GFP expression cassette, the rat red, FITC, or Alexa 568. In some experiments, a chicken anti-MCH
MCH promoter was synthesized by PCR from a rat genomic se- (Biomedical AG, Switzerland) that gave the same staining pattern
quence (kindly provided by Dr. R. Thompson; Thompson and Wat- as the rabbit antiserum was used at 1:2000 dilution for dual localiza-
son, 1990) and ligated upstream of the enhanced GFP gene in plas- tion of hypocretin and MCH.
mid pEGFP-1 (Clontech) using the XhoI and EcoRI restriction sites to
yield plasmid MCH-pEGFP-1. The MCH-eGFP expression cassette Brain Slice Preparation
was then cloned into a 13.9 kb rAAV2 tripartite producer plasmid Hypothalamic slices were prepared from 2- to 4-week-old mice in
(pAAV/stuffer/rep-cap/neotk #17) to enable stable rAAV2 producer
which rAAV-MCH or rAAV-CMV had been injected into the hypothal-
cell line isolation. pAAV/stuffer/rep-cap/neotk #17 contains (1) the
amus as described above. Coronal slices (250–400 m) containing
native AAV2 rep and cap genes, (2) the neomycin resistance gene
the hypothalamus were gassed with ACSF (95% O2, 5% CO2) thatfor stable cell line selection, and (3) a stuffer DNA fragment flanked
contained 124 mM NaCl, 3.3 mM KCl, 2 mM MgCl2, 2 mM CaCl2,by XbaI sites and the AAV2 inverted terminal repeats (Figure 1). The
1.23 mM NaH2PO4, 26 mM NaHCO3, and 10 mM glucose (pH 7.4 withstuffer DNA fragment was removed following XbaI digestion, and
NaOH). The recording chamber (Warner Instruments), maintained atthe 1.4 kb MCH-GFP cassette (isolated from plasmid MCH-pEGFP-1
36C–37C, was mounted on an Olympus BX51WI upright micro-by XhoI and AflII double digestion) was cloned between the AAV2
scope equipped with video-enhanced infrared-differential interfer-inverted terminal repeats by blunt-end ligation. This resulted in the
ence contrast (DIC) and fluorescence.final rAAV2 producer plasmid pAAV/MCH-eGFP/rep-cap/neotk (Fig-
ure 1). The fidelity of the construct was confirmed by DNA se-
Whole-Cell Patch-Clamp Recordingquencing.
Whole-cell voltage- and current-clamp recording was done with
whole-cell pipettes containing 145 mM KMeSO4, 1 mM MgCl2, 10rAAV Production
mM HEPES, 1.1 mM EGTA, 2 mM Mg-ATP, and 0.5 mM Na2-GTPrAAV2/MCHV was produced and purified using methods previously
described (Clark et al., 1999). Briefly, a producer cell line (1B3) was (pH 7.3 with KOH). MCH neurons were detected by direct visual
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observation of GFP fluorescence. Slow and fast capacitance com- Horvath, T.L., Cone, R.D., and Low, M.J. (2001). Leptin activates
anorexigenic POMC neurons through a neural network in the arcuatepensation was done using Pulse software (Heka Elektronik). An
EPC9 amplifier and Pulse software were used for data acquisition nucleus. Nature 411, 480–484.
(Heka Elektronik). PulseFit (Heka Elektronik), Axograph (Axon Instru- Cowley, M.A., Pronchuk, N., Fan, W., Dinulescu, D.M., Colmers,
ments), and Igor Pro (WaveMetrics, Lake Oswego, OR) software W.F., and Cone, R.D. (1999). Integration of NPY, AGRP, and melano-
were used for analysis. Liquid junction potential corrections were cortin signals in the hypothalamic paraventricular nucleus: evidence
done offline. Access resistance was continuously monitored and of a cellular basis for the adipostat. Neuron 124, 155–163.
only stable cells (changes 	10%) were used for analysis. Drugs
de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X.-B., Foye, P.E., Dan-
were delivered by a flow pipe with a large 350 m diameter aimed
ielson, P.E., Fukuhara, C., Battenberg, E.L.F., Gautvik, V.T., Bartlett,
at the recorded cell.
F.S., II, et al. (1998). The hypocretins: hypothalamus-specific pep-
PSCs  5 pA were detected in Axograph 4.8, using a double
tides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95,
exponential function sensitive to the kinetics of rise and decay. Data
322–327.
in the Results section are expressed as mean  SEM, with ANOVA
During, M.J., and Leone, P. (1995). Adeno-associated virus vectorsused for the statistical analysis.
for gene therapy of neurodegenerative disorders. Clin. Neurosci.
3, 292–300.Reagents
Some reagents were purchased from Sigma (St. Louis, MO) and Eggermann, E., Bayer, L., Serafin, M., Saint-Mleux, B., Bernheim,
included dl-2-amino-5-phosponovaleric acid (AP5), bicuculline L., Machard, D., Jones, B.E., and Muhlethaler, M. (2003). The wake-
methiodide (BIC), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), promoting hypocretin-orexin neurons are in an intrinsic state of
()-
-amino-3-hydroxy-5-methylisoxazole-4-propionic acid hy- membrane depolarization. J. Neurosci. 23, 1557–1562.
drobromide (AMPA hydrobromide), N-methyl-d-aspartate (NMDA), Ehlers, C.L., Somes, C., Lopez, A., Kirby, D., and Rivier, J.E. (1997).
5-aminomethyl-3-hydroxyisoxazole (muscimol), l-glutamate, adeno- Electrophysiological actions of neuropeptide Y and its analogs: new
sine-5-triphosphate (ATP), norepinephrine, and serotonin. Neuro- measures for anxiolytic therapy? Neuropsychopharmacology 17,
peptide Y (human, rat) and hypocretin-1/orexin A (mouse) were ob- 34–43.
tained from Phoenix Pharmaceutical, Inc. (Ac-Nle4, Asp5, D-Phe7,
Elias, C.F., Saper, C.B., Maratos-Flier, E., Tritos, N.A., Lee, C., Kelly,Lys10)-cyclo-
-MSH(4-10)-amide (MTII) and (Ac-Nle4, Asp5, D-2-Nal7,
J., Tatro, J.B., Hoffman, G.E., Ollmann, M.M., Barsh, G.S., et al.Lys10)-cyclo-
-MSH(4-10)-amide (SHU9119) were purchased from
(1998). Chemically defined projections linking the mediobasal hypo-Bachem. Hypocretin-2 (Hcrt-2) was synthesized by the Stanford
thalamus and the lateral hypothalamic area. J. Comp. Neurol.University Peptide Facility. -muscarine chloride (muscarine) was
402, 442–459.obtained from Tocris, and tetrodotoxin (TTX) was obtained from
Elias, C.F., Lee, C.E., Kelly, J.F., Ahima, R.S., Kuhar, M., Saper, C.B.,Alomone Labs, Ltd. (Jerusalem, Israel).
and Elmquist, J.K. (2001). Characterization of CART neurons in the
rat and human hypothalamus. J. Comp. Neurol. 432, 1–19.Acknowledgments
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